GRACE

cancergrace.org

 

GRACE
Avatar

Personalized Response-Driven Surgery and Adjuvant Therapy After Neoadjuvant Ipi & Nivo in Resectable Stage III Melanoma: The PRADO Trial

By GRACE FEATURING Vernon Sondak
January 19, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

23:48
Tumor Lysis Syndrome

Strategies for Preventing and Managing Tumor Lysis Syndrome-Associat…

Feat. M. Geyer

Featured Video

19:14
Bristol Myers Squibb Hematology

Study Results of a Treatment Option for AML Patients

Feat. J. Mccloskey, T. Leblanc
2022 Melanoma Video Library
04:58
GRACE

Adjuvant IO in Advanced Stage Melanoma

Feat. M. McKean
04:53
GRACE

Neoadjuvant Therapy for Advanced Melanoma: Does It Give a Better Imm…

Feat. V. Sondak
03:04
GRACE

Personalized Response-Driven Surgery and Adjuvant Therapy After Neoa…

Feat. V. Sondak
06:43
GRACE

Pros and Cons of Neoadjuvant Therapy for Melanoma

Feat. V. Sondak
05:16
GRACE

Patient Selection for 1L Therapy in Stage 4 Melanoma

Feat. V. Sondak
05:22
GRACE

Treatment for Metastatic Melanoma

Feat. V. Sondak
03:39
GRACE

Incidence Trends in Melanoma

Feat. V. Sondak
04:04
GRACE

Clinical Trials in Melanoma

Feat. M. Postow
02:49
GRACE

Major Advances in Uveal Melanoma

Feat. M. Postow
04:28
GRACE

BRAF Mutated Melanoma

Feat. M. Postow
03:10
GRACE

Side Effects of Immunotherapy in Melanoma

Feat. M. Postow
08:00
GRACE

Immunotherapy in Treatment of Melanoma

Feat. M. Postow
05:50
GRACE

Melanoma and Current Treatment Options

Feat. M. Postow